# Translational Therapeutics (United States)

**Type:** Institutions  
**Canonical URL:** https://scholariq.org/institutions/translational-therapeutics-united-states/

## Facts

| Field | Value |
| --- | --- |
| Avg h-index | 80.8 |
| Citations | 997,601 |
| City | Arlington |
| Country | US |
| Description | Translational Therapeutics (United States) is a research organisation in Arlington, US. OpenAlex records 4,852 works and 997,601 citations for it. 946 researchers list it as their most recent affiliation. |
| Homepage | http://transrx-inc.com/ |
| OpenAlex ID | https://openalex.org/I4210125521 |
| Region | Massachusetts |
| Researchers | 946 |
| ROR ID | https://ror.org/02z3rcy16 |
| Type | company |
| Works | 4,852 |

## University papers

Showing 12 of 17.

- [Brain-Region-Specific Organoids Using Mini-bioreactors for Modeling ZIKV Exposure](https://scholariq.org/papers/brain-region-specific-organoids-using-mini-bioreactors-for-modeling-zikv/)
- [Prevalence of Parkinson’s disease across North America](https://scholariq.org/papers/prevalence-of-parkinson-s-disease-across-north-america/)
- [Central Nervous System Cancers, Version 3.2020, NCCN Clinical Practice Guidelines in Oncology](https://scholariq.org/papers/central-nervous-system-cancers-version-3-2020-nccn-clinical-practice-guidelines/)
- [Geographic and Ethnic Variation in Parkinson Disease: A Population-Based Study of US Medicare Beneficiaries](https://scholariq.org/papers/geographic-and-ethnic-variation-in-parkinson-disease-a-population-based-study-of/)
- [A nuclease that mediates cell death induced by DNA damage and poly(ADP-ribose) polymerase-1](https://scholariq.org/papers/a-nuclease-that-mediates-cell-death-induced-by-dna-damage-and-poly-adp-ribose/)
- [Epigenetic mechanisms in neurogenesis](https://scholariq.org/papers/epigenetic-mechanisms-in-neurogenesis/)
- [Incidence of Parkinson disease in North America](https://scholariq.org/papers/incidence-of-parkinson-disease-in-north-america/)
- [Neurologist care in Parkinson disease](https://scholariq.org/papers/neurologist-care-in-parkinson-disease/)
- [NCCN Guidelines® Insights: Central Nervous System Cancers, Version 2.2022](https://scholariq.org/papers/nccn-guidelines-insights-central-nervous-system-cancers-version-2-2022/)
- [National randomized controlled trial of virtual house calls for Parkinson disease](https://scholariq.org/papers/national-randomized-controlled-trial-of-virtual-house-calls-for-parkinson/)
- [A sensitive assay for ABCA1-mediated cholesterol efflux using BODIPY-cholesterol](https://scholariq.org/papers/a-sensitive-assay-for-abca1-mediated-cholesterol-efflux-using-bodipy-cholesterol/)
- [Pathologic Accumulation of α-Synuclein and Aβ in Parkinson Disease Patients With Dementia](https://scholariq.org/papers/pathologic-accumulation-of-synuclein-and-a-in-parkinson-disease-patients-with/)

## University researchers

- [Allison W. Willis](https://scholariq.org/researchers/allison-w-willis/)

## University top topics

Showing 8 of 25.

- [Genetic Associations and Epidemiology](https://scholariq.org/topics/genetic-associations-and-epidemiology/)
- [Inflammatory mediators and NSAID effects](https://scholariq.org/topics/inflammatory-mediators-and-nsaid-effects/)
- [Circadian rhythm and melatonin](https://scholariq.org/topics/circadian-rhythm-and-melatonin/)
- [Immune Cell Function and Interaction](https://scholariq.org/topics/immune-cell-function-and-interaction/)
- [CAR-T cell therapy research](https://scholariq.org/topics/car-t-cell-therapy-research/)
- [Diabetes, Cardiovascular Risks, and Lipoproteins](https://scholariq.org/topics/diabetes-cardiovascular-risks-and-lipoproteins/)
- [Lipoproteins and Cardiovascular Health](https://scholariq.org/topics/lipoproteins-and-cardiovascular-health/)
- [Immunotherapy and Immune Responses](https://scholariq.org/topics/immunotherapy-and-immune-responses/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.